Thomas Scior

2.3k total citations
73 papers, 1.8k citations indexed

About

Thomas Scior is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Thomas Scior has authored 73 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 13 papers in Organic Chemistry and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Thomas Scior's work include Computational Drug Discovery Methods (10 papers), Ion channel regulation and function (8 papers) and Vanadium and Halogenation Chemistry (7 papers). Thomas Scior is often cited by papers focused on Computational Drug Discovery Methods (10 papers), Ion channel regulation and function (8 papers) and Vanadium and Halogenation Chemistry (7 papers). Thomas Scior collaborates with scholars based in Mexico, Germany and United States. Thomas Scior's co-authors include Philippe Bernard, José L. Medina‐Franco, Karina Martínez‐Mayorga, Quoc‐Tuan Do, Stefan Laufer, Andreas Bender, Christa E. Müller, Karina Cuanalo-Contreras, Gary Tresadern and Dimitris K. Agrafiotis and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Thomas Scior

71 papers receiving 1.7k citations

Peers

Countries citing papers authored by Thomas Scior

Since Specialization

Citations

This map shows the geographic impact of Thomas Scior's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Scior with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Scior more than expected).

Fields of papers citing papers by Thomas Scior

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Scior. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Scior. The network helps show where Thomas Scior may publish in the future.

Co-authorship network of co-authors of Thomas Scior

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Scior. A scholar is included among the top collaborators of Thomas Scior based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Scior. Thomas Scior is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The α/β3 complex of human voltage-gated sodium channel hNav1.7 to study mechanistic differences in presence and absence of auxiliary subunit β3 2025 ·Journal of Molecular Modeling ·(unknown), (unknown), (unknown), Francisco J. Meléndez, Thomas Scior	0
2	Molecular Dynamics and Docking Simulations of Homologous RsmE Methyltransferases Hints at a General Mechanism for Substrate Release upon Uridine Methylation on 16S rRNA 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Thomas Scior	2
3	Targeting the Human Influenza a Virus: The Methods, Limitations, and Pitfalls of Virtual Screening for Drug-like Candidates Including Scaffold Hopping and Compound Profiling 2023 ·Viruses ·Thomas Scior, Karina Cuanalo-Contreras, (unknown), Ygnacio Martínez‐Laguna	0
4	Are vanadium complexes druggable against the main protease Mpro of SARS-CoV-2? – A computational approach 2021 ·Inorganica Chimica Acta ·Thomas Scior, Hassan H. Abdallah, (unknown), (unknown), Dieter Rehder	20
5	Identification of residues for chaperone-like activity of OppA protein in Yersinia pseudotuberculosis 2020 ·AMB Express ·(unknown), Thomas Scior, (unknown), (unknown)	2
6	Predicting a double mutant in the twilight zone of low homology modeling for the skeletal muscle voltage-gated sodium channel subunit beta-1 (Nav1.4 β1) 2015 ·Computational and Structural Biotechnology Journal ·Thomas Scior, (unknown), (unknown), (unknown), (unknown), (unknown), Eduardo M. Salinas-Stefanon	5
7	Antiprotozoal Nitazoxanide Derivatives: Synthesis, Bioassays and QSAR Study Combined with Docking for Mechanistic Insight 2015 ·Current Computer - Aided Drug Design ·Thomas Scior, (unknown), Subhash Ajmani, (unknown), (unknown), Emanuel Hernández‐Núñez, Rosa Moo‐Puc, (unknown), Gabriel Navarrete‐Vázquez	11
8	What do you know about... Molecular Dynamics 2014 ·(unknown), Thomas Scior	1
9	¿Qué sabe Ud. acerca de…QSAR? 2012 ·LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) ·(unknown), Thomas Scior	1
10	An In-Silico Approach to Primaquine Binding to Trp756 in the External Vestibule of Sodium Channel Nav 1.4 2012 ·Biophysical Journal ·(unknown), (unknown), Thomas Scior, (unknown), Lourdes Millán-Pérez-Peña	4
11	Estudios preliminares sobre el efecto analgésico del extracto de hojas de Ageratina glabrata en dos modelos térmicos de dolor agudo 2011 ·LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) ·Guadalupe García, (unknown), (unknown), (unknown), Thomas Scior	3
12	Preliminary studies on the analgesic effect of leaf extract from Ageratina glabrata in two thermal models of acute pain 2011 ·Guadalupe García, (unknown), (unknown), (unknown), Thomas Scior	3
13	Reverse Pharmacognosy: Another Way to Harness the Generosity of Nature 2010 ·Current Pharmaceutical Design ·(unknown), (unknown), Thomas Scior, Philippe Bernard, Luc Morin‐Allory	18
14	How to Recognize and Workaround Pitfalls in QSAR Studies: A Critical Review 2009 ·Current Medicinal Chemistry ·Thomas Scior, José L. Medina‐Franco, Quoc‐Tuan Do, Karina Martínez‐Mayorga, (unknown), Philippe Bernard	139
15	Structure-function analysis of two variants of mumps virus hemagglutinin-neuraminidase protein 2009 ·The Brazilian Journal of Infectious Diseases ·Gerardo Santos‐López, Thomas Scior, (unknown), Verónica Vallejo‐Ruiz, Irma Herrera‐Camacho, José Tapia-Ramı́rez, Julio Reyes‐Leyva	16
16	Application of Drug Repositioning Strategy to TOFISOPAM 2008 ·Current Medicinal Chemistry ·Philippe Bernard, (unknown), Patrick Favetta, Quoc‐Tuan Do, (unknown), (unknown), Thomas Scior, Claire Lugnier	19
17	Large Compound Databases for Structure-Activity Relationships Studies in Drug Discovery 2007 ·Mini-Reviews in Medicinal Chemistry ·Thomas Scior, Philippe Bernard, José L. Medina‐Franco, Gerald M. Maggiora	31
18	Isoniazid is Not a Lead Compound for its Pyridyl Ring Derivatives,Isonicotinoyl Amides, Hydrazides, and Hydrazones: A Critical Review 2006 ·Current Medicinal Chemistry ·Thomas Scior, (unknown)	54
19	Preliminary screening of some tropical plants for anti-tyrosinase activity 2002 ·Journal of Ethnopharmacology ·(unknown), Éric Arnoult, Thomas Scior, Quoc‐Tuan Do, Philippe Bernard	134
20	Ethnopharmacology and bioinformatic combination for leads discovery: application to phospholipase A2 inhibitors 2001 ·Phytochemistry ·Philippe Bernard, Thomas Scior, (unknown), Marcel Hibert, Jean‐Yves Berthon	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact